Product information
From Health Canada
Current status:
Dormant
Current status date:
2019-08-07
Original market date: See footnote 1
1994-12-31
Product name:
DIOPTICON LIQ 0.1%
DIN:
02026546 Electronic product monograph is not available
Company:
PHARMA STULLN INC.
6500 Trans Canada Highway, Suite 400
Pointe-Claire
Quebec
Canada
H9R 0A5
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Ophthalmic
Number of active ingredient(s):
1
Schedule(s):
OTC
American Hospital Formulary Service (AHFS): See footnote 3
52:32.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
S01GA01 NAPHAZOLINE
Active ingredient group (AIG) number:See footnote5
0103282001
Active ingredient(s) | Strength |
---|---|
NAPHAZOLINE HYDROCHLORIDE | 0.1 % |